Advertisement
Research Article

Human Neutrophil Peptide-1 (HNP-1): A New Anti-Leishmanial Drug Candidate

  • Sara Dabirian,

    Affiliation: Molecular Immunology and Vaccine Research Laboratory, Pasteur Institute of Iran, Tehran, Iran

    X
  • Yasaman Taslimi,

    Affiliation: Molecular Immunology and Vaccine Research Laboratory, Pasteur Institute of Iran, Tehran, Iran

    X
  • Farnaz Zahedifard,

    Affiliation: Molecular Immunology and Vaccine Research Laboratory, Pasteur Institute of Iran, Tehran, Iran

    X
  • Elham Gholami,

    Affiliation: Molecular Immunology and Vaccine Research Laboratory, Pasteur Institute of Iran, Tehran, Iran

    X
  • Fatemeh Doustdari,

    Affiliation: Molecular Immunology and Vaccine Research Laboratory, Pasteur Institute of Iran, Tehran, Iran

    X
  • Mahdieh Motamedirad,

    Affiliation: Virology Department, Pasteur Institute of Iran, Tehran, Iran

    X
  • Shohreh Khatami,

    Affiliation: Biochemistry Department, Pasteur Institute of Iran, Tehran, Iran

    X
  • Kayhan Azadmanesh,

    Affiliation: Virology Department, Pasteur Institute of Iran, Tehran, Iran

    X
  • Susanne Nylen,

    Affiliation: Department of Microbiology Tumor and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden

    X
  • Sima Rafati mail

    s_rafati@yahoo.com, sima-rafatisy@pasteur.ac.ir

    Affiliation: Molecular Immunology and Vaccine Research Laboratory, Pasteur Institute of Iran, Tehran, Iran

    X
  • Published: October 17, 2013
  • DOI: 10.1371/journal.pntd.0002491

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.